Purified Roswell Park cultured antilymphocytic globulin RPMI-CALG: preparation and clinical trial.
D000328:Adult; D000818:Animals; D000961:Antilymphocyte Serum / Q000138:chemical synthesis / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects; D004804:Eosinophils / Q000187:drug effects; D005260:Female; D006084:Graft Rejection; D006648:Histocompatibility; D006736:Horses; D006801:Humans; D007114:Immunization; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D001379:Azathioprine; D011241:Prednisone